TX-MAVENIR
Mavenir, the cloud-native network infrastructure provider building the future of networks, today announces that its world-leading SpamShield messaging fraud prevention technology is driving a steep decline in the volume of spam and scam messages for Globe Telecom, Inc. in the Philippines – demonstrating its ability to disincentivize scammers and successfully boost customer protection against fraudulent, malicious and nuisance messaging. The Philippines is one of the large SMS markets in the world, and addressing the aggressive growth in the volume of spam and scam messaging is a key priority for the government’s National Telecommunications Commission (NTC).
In an impressive year-on-year improvement, Mavenir’s SpamShield has enabled the Philippines’ largest mobile operator to achieve a record 67% drop in blocked spam and scam SMS, plus a 74% decline in bank-related spam and scam messages during the first quarter of 2024, compared with the same period in 2023. The total number of blocked spam and scam SMS messages fell substantially from 1.1 billion in Q1 2023 to 362.8 million in Q1 2024. Over the same time span, the number of scam SMS messages directly reported by customers declined 44% year-on-year – from 610 in Q1 2023 to 342 in Q1 2024. Mavenir’s SpamShield technology has delivered an immediate and measurable impact for Globe – which reported blocking over 5 billion spam and scam messages in 2023 – by significantly raising the technical barriers to send fraudulent campaigns, increasing the cost of fraud, and removing profit incentives for scammers.
Mavenir’s SpamShield operates as a powerful SMS firewall – incorporating advanced monitoring, adaptive analytics, and real-time machine learning (ML) capabilities – that empowers Communication Service Providers (CSPs) to automatically block millions of fraudulent messages before they ever reach subscribers. SpamShield’s AI/ML detection algorithms adapt to current network conditions and subscriber behavior to continually detect spammer and fraudster attempts – enabling CSPs to quickly identify and act on potential threats and harmful events. This unique and innovative solution delivers an improved experience and greater security for customers, while protecting CSPs’ revenues from the negative costs of malicious activity.
Commenting on its successful spam reduction initiative, Anton Bonifacio, Chief Information Security Officer for Globe said: “Mavenir’s SpamShield technology has proven its ability to offer timely, precise, and effective threat detection and response, playing a central role in this dramatic reduction of spam and scam SMS traffic across our network to the immense benefit of all our customers. We now consider SpamShield an essential component of Globe’s anti-spam strategy moving forward, as we increase our innovation investment and strengthen our defenses against the tide of increasingly sophisticated fraudulent activity.”
Ilia Abramov, VP & GM of the Security Business Unit at Mavenir added: “Globe’s implementation of our SpamShield technology underlines its stringent and highly proactive approach to safeguarding customers, protecting users through the most robust and intelligent anti-spam messaging solution available today. The massive drop in blocked messages evidenced by these remarkable numbers shows how SpamShield achieves its transformative results in operation – making fraudulent activity prohibitively difficult and unprofitable for scammers, who then move on to easier and less protected targets including other operators and OTT channels such as WhatsApp. Globe is at the forefront of industry efforts to protect subscribers from this growing and ever-evolving array of threats, and we will continue to vigorously support its efforts to optimize communication safety and messaging authenticity in the Philippines.”
Notes to editors:
- Combating Messaging Scam and Fraud: A Telecom TV panel session with Globe recorded at MWC24: https://www.mavenir.com/resources/combating-messaging-scam-and-fraud/
About Globe:
Globe Telecom, Inc. is a leading full-service telecommunications company in the Philippines and publicly listed in the PSE with the stock symbol GLO. The company serves the telecommunications and technology needs of consumers and businesses across an entire suite of products and services including mobile, fixed, broadband, data connectivity, internet and managed services. It offers innovative digital solutions in the areas of fintech, healthtech, adtech, climatetech, shared services and venture capital. In 2019, Globe became a signatory to the United Nations Global Compact, committing to implement universal sustainability principles. Its principals are Ayala Corporation and Singtel, acknowledged industry leaders in the country and in the region.
About Mavenir:
Mavenir is building the future of networks today with cloud-native, AI-enabled solutions which are green by design, empowering operators to realize the benefits of 5G and achieve intelligent, automated, programmable networks. As the pioneer of Open RAN and a proven industry disruptor, Mavenir’s award-winning solutions are delivering automation and monetization across mobile networks globally, accelerating software network transformation for 300+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers. For more information, please visit www.mavenir.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240529690737/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
